Difference between revisions of "Center for Medicine in the Public Interest"
(→CMPI Board of Directors) |
(→CMPI Advisory Board) |
||
| Line 23: | Line 23: | ||
==CMPI Advisory Board== | ==CMPI Advisory Board== | ||
| − | *[[Joesph L. Bast]] | + | *[[Joesph L. Bast]] President and CEO, The [[Heartland Institute]], Chicago, IL |
| − | |||
| − | *[[John E. Calfee]] | + | *[[John E. Calfee]] Senior Fellow, [[American Enterprise Institute]], Washington, D.C. |
| − | |||
| − | *[[Joseph A. DiMasi]], Ph.D. | + | *[[Joseph A. DiMasi]], Ph.D. Director of Economic Analysis, [[Tufts Center for the Study of Drug Development]], Tufts University, Boston, MA |
| − | |||
| − | *[[Helen Disney]] | + | *[[Helen Disney]] Director, [[Stockholm Network]], London, England |
| − | |||
| − | *[[John Kamp]] | + | *[[John Kamp]] Executive Director, [[Coalition for Healthcare Communication]] |
| − | |||
| − | *[[Sam Kazman]] | + | *[[Sam Kazman]] General Counsel, [[Competitive Enterprise Institute]] |
| − | |||
| − | *Dr. [[Merrill Mathews]], Jr. | + | *Dr. [[Merrill Mathews]], Jr. Resident Scholar, [[Institute for Policy Innovation]] Director, [[Council for Affordable Health Insurance]] |
| − | |||
| − | |||
| − | *[[David McIntosh]] | + | *[[David McIntosh]] Attorney, [[Mayer, Brown, Rowe & Maw]] LLP, Washington, D.C. |
| − | |||
| − | *[[Julian Morris]] | + | *[[Julian Morris]] Director, [[International Policy Network]], London |
| − | |||
| − | *[[Tomas J. Philipson]] | + | *[[Tomas J. Philipson]] Professor, The Harris School, Chicago, IL |
| − | |||
| − | *[[Stephen Pollard]] | + | *[[Stephen Pollard]] Senior Fellow at the [[Centre for the New Europe]], Brussels, Belgium |
| − | |||
| − | *[[William Roper]] | + | *[[William Roper]] CEO, University of North Carolina Health Care System |
| − | |||
| − | *[[Ellen V. Sigal]], Ph.D. | + | *[[Ellen V. Sigal]], Ph.D. Founder and Chairperson, [[Friends of Cancer Research]] |
| − | |||
| − | *[[Samuel C. Silverstein]], M.D. | + | *[[Samuel C. Silverstein]], M.D. John C. Dalton Professor and Chairman, Department of Physiology and Cellular Biophysics, Columbia University Professor of Medicine, College of Physicians and Surgeons, Columbia University |
| − | |||
| − | |||
| − | *[[Philip Stieg]], M.D. | + | *[[Philip Stieg]], M.D. Professor and Chairman, Department of Neurological Surgery, Weill Medical College Neurosurgeon-in-Chief, New York-Presbyterian Hospital |
| − | |||
| − | |||
| − | *[[Daniel E. Troy]] | + | *[[Daniel E. Troy]] Former Chief Counsel of the [[Food and Drug Administration]] (FDA) Partner in the Washington, New York Offices of [[Sidley Austin Brown & Wood]] |
| − | |||
| − | |||
| − | *[[Grace Marie Turner]] | + | *[[Grace Marie Turner]] President, The [[Galen Institute]] |
| − | |||
| − | *[[Ben Zycher]] | + | *[[Ben Zycher]] Senior Fellow in Economics, [[Pacific Research Institute]] Adjunct scholar, [[Cato Institute]], [[Claremont Institute]] |
| − | |||
| − | |||
Revision as of 18:35, 5 June 2007
CMPI Board of Directors
The CMPI Board of Directors is comprised of some of the nation's leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.
- Bruce Booth Principal, Atlas Venture
- Bruce Brandfon Publisher, Scientific American
- Fred Goodwin, M.D. Professor of Psychiatry, The George Washington University Medical Center
- Dennis Johnson Vice President, Policy and External Affairs at The Children's Health Fund
- Suzanne Pattee, J.D.Vice president, Public Policy and Patient Affairs for the Cystic Fibrosis Foundation
- Steven Sammut Lecturer, Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania
- Mark Thornton, M.D., Ph.D.Chairman and President, Sarcoma Foundation of America
- Michael Weber, M.D.Associate Dean and Professor of Medicine, SUNY Downstate College of Medicine, Brooklyn, New York
- Raymond Woosley, M.D., Ph.D.President and CEO, C-Path Institute
CMPI Advisory Board
- Joesph L. Bast President and CEO, The Heartland Institute, Chicago, IL
- John E. Calfee Senior Fellow, American Enterprise Institute, Washington, D.C.
- Joseph A. DiMasi, Ph.D. Director of Economic Analysis, Tufts Center for the Study of Drug Development, Tufts University, Boston, MA
- Helen Disney Director, Stockholm Network, London, England
- John Kamp Executive Director, Coalition for Healthcare Communication
- Sam Kazman General Counsel, Competitive Enterprise Institute
- Dr. Merrill Mathews, Jr. Resident Scholar, Institute for Policy Innovation Director, Council for Affordable Health Insurance
- David McIntosh Attorney, Mayer, Brown, Rowe & Maw LLP, Washington, D.C.
- Julian Morris Director, International Policy Network, London
- Tomas J. Philipson Professor, The Harris School, Chicago, IL
- Stephen Pollard Senior Fellow at the Centre for the New Europe, Brussels, Belgium
- William Roper CEO, University of North Carolina Health Care System
- Ellen V. Sigal, Ph.D. Founder and Chairperson, Friends of Cancer Research
- Samuel C. Silverstein, M.D. John C. Dalton Professor and Chairman, Department of Physiology and Cellular Biophysics, Columbia University Professor of Medicine, College of Physicians and Surgeons, Columbia University
- Philip Stieg, M.D. Professor and Chairman, Department of Neurological Surgery, Weill Medical College Neurosurgeon-in-Chief, New York-Presbyterian Hospital
- Daniel E. Troy Former Chief Counsel of the Food and Drug Administration (FDA) Partner in the Washington, New York Offices of Sidley Austin Brown & Wood
- Grace Marie Turner President, The Galen Institute
- Ben Zycher Senior Fellow in Economics, Pacific Research Institute Adjunct scholar, Cato Institute, Claremont Institute
